Arrowstreet Capital, Limited Partnership Meridian Bioscience Inc Transaction History

Arrowstreet Capital, Limited Partnership

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$19.76 - $29.89 $9.27 Million - $14 Million	-469,032 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$15.73 - $21.66 $1.77 Million - $2.44 Million	-112,664 Reduced 19.37%	469,032 $8.77 Million
Q3 2020 Nov 12, 2020	BUY	$13.54 - $26.41 $238,303 - $464,816	17,600 Added 3.12%	581,696 $9.88 Million
Q2 2020 Aug 12, 2020	BUY	$7.84 - $23.29 $3.14 Million - $9.34 Million	401,096 Added 246.07%	564,096 $13.1 Million
Q1 2020 May 15, 2020	SELL	$5.57 - $11.5 $550,160 - $1.14 Million	-98,772 Reduced 37.73%	163,000 $1.37 Million
Q4 2019 Feb 13, 2020	BUY	$7.9 - $10.14 $309,285 - $396,981	39,150 Added 17.59%	261,772 $2.56 Million
Q3 2019 Nov 14, 2019	BUY	$9.17 - $12.01 $287,241 - $376,201	31,324 Added 16.37%	222,622 $2.11 Million
Q2 2019 Aug 14, 2019	SELL	$10.88 - $17.6 $237,140 - $383,609	-21,796 Reduced 10.23%	191,298 $2.27 Million
Q1 2019 May 15, 2019	SELL	$15.51 - $17.61 $1.21 Million - $1.37 Million	-77,765 Reduced 26.74%	213,094 $3.75 Million
Q4 2018 Feb 14, 2019	BUY	$14.52 - $19.72 $1.67 Million - $2.26 Million	114,754 Added 65.16%	290,859 $5.05 Million
Q3 2018 Nov 14, 2018	BUY	$14.85 - $16.35 $1.58 Million - $1.74 Million	106,140 Added 151.7%	176,105 $2.62 Million
Q2 2018 Aug 14, 2018	BUY	$13.8 - $16.8 $101,844 - $123,984	7,380 Added 11.79%	69,965 $1.11 Million
Q1 2018 May 14, 2018	SELL	$13.8 - $16.2 $196,208 - $230,331	-14,218 Reduced 18.51%	62,585 $889,000
Q4 2017 Feb 09, 2018	BUY	$13.55 - $15.8 $1.04 Million - $1.21 Million	76,803	76,803 $1.08 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.